TPST Stock: Tempest Therapeutics, Inc. Stock Price, Analysis & Insights
Get live tpst stock price $9.24, comprehensive Tempest Therapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time tpst stock data and investment insights.
Loading chart...
Company Overview
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. The company was founded in 2011 and is headquartered in South San Francisco, California. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc.
Company Information
- CEO
- Stephen R. Brady LLM
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 24
Contact Information
- Website
- https://www.tempesttx.com
- Address
- 7000 Shoreline Court
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: -2.33) may provide portfolio stability
Business Model & Strategy
Tempest Therapeutics, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Stephen R. Brady LLM, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Tempest Therapeutics, Inc. competes in the Biotechnology within the broader Healthcare. With 41.0 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Tempest Therapeutics, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Tempest Therapeutics, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Tempest Therapeutics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Tempest Therapeutics, Inc.
- ⚠Investors should consider how Tempest Therapeutics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
41.03M
P/E Ratio
-0.95
Beta
-2.33
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 41.03M market capitalization
- Trading Volume: 26.32K shares traded today
- Price Range: 52-week range of $5.36 - $13.65
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc. (TPST) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 41.03M, the company represents a significant player in its market. The stock is currently trading at $9.24 with a negativedaily change of 1.49%.
The company's 24 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.95, beta of -2.33, and 52-week price range from $5.36 to $13.65when evaluating investment opportunities.
Why Invest in Tempest Therapeutics, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Stephen R. Brady LLM
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.